Sleep Disorders and Circadian Rhythms*

Date: Tuesday, September 17, 2024
Time: 11:00 AM to 12:30 PM
Room: Lake Monroe B
Track: Special Interest Group (SIG)
Level: ANA2024

Description

The Sleep Disorders and Circadian Rhythms Special Interest Group will feature three speakers. Dr. Devin Brown will speak about sleep and obstructive sleep apnea. Dr. Tiffany Braley will speak about sleep and multiple sclerosis. Dr. Bryce Mander will speak about sleep and cognitive reserve. These dynamic speakers will present innovative research in how sleep and sleep interventions impact neurological disorders such as stroke and multiple sclerosis. Dr. Mander’s talk on sleep and cognitive reserve has potential impact on neurological disorders broadly that negatively impact cognitive function such as neurodegenerative diseases.

Objectives

  • Identify ow sleep disorders impact neurological diseases and symptoms related to those diseases such as cognitive dysfunction. 

  • Utilize new evidence in the evaluation of sleep disorders in neurological diseases. 

  • Apply new evidence in managing patients with neurological disorders who have sleep disturbances. 

  • Sleep Disturbances Induced by TDP-43 Proteinopathy are Rescued by ATXN2 Knockdown in Drosophila and Mouse Models of Sporadic ALS

    Description

    Disruptions in sleep have been described in patients with TDP-43 proteinopathies, including amyotrophic lateral sclerosis and frontotemporal dementia, but sleep studies in corresponding animal models are lacking. We previously showed that ubiquitous TDP-43 overexpression in Drosophila resulted in severe sleep disturbance that was ameliorated by knockdown of the RNA binding protein Ataxin-2 (ATXN2), reductions in which are known to reduce TDP-43 pathology in flies and mice. Translatability of these studies would be clarified by delineating cell types responsible for sleep phenotypes and studying a mammalian correlate. We will discuss our findings in Drosophila overexpressing TDP-43 selectively in neurons. We will then describe our findings in aged TAR4 mice that also overexpress TDP-43 neuronally, including therapeutic effects of AAV-RNAi-mediated reduction of ATXN2. Collectively, these results provide important information regarding the role of neuronal TDP-43 pathology on sleep over time, as well as the role of a potential therapeutic approach.

  • Sleep Stage Specific Effects of Sleep Apnea on Cerebrovascular Pathology and Memory in Older Adults at Risk for Alzheimer's Disease

    Description

    Sleep apnea is associated with cognitive decline and increased risk for dementia in older adults, but the exact features of sleep apnea driving this association and the downstream mechanisms of this association remain unclear. In this presentation, I will show data from two independent studies linking severity of hypoxemia during REM sleep with memory impairment. In the first study, this association is moderated by older age and APOE4 positive status, such that older adults and those with APOE4 positive status show stronger associations between sleep apnea severity during REM sleep and memory performance. In the second study, this association is mediated by the effects of hypoxemia during REM sleep on cerebrovascular pathology in the frontal cortex, with downstream associations with medial temporal lobe structural integrity. These findings have important implications for how sleep apnea severity should be evaluated in older adults and in populations with REM-dominant expression profiles.